Telehealth GLP-1 Red Flags: 5 Warning Signs to Avoid
Not every telehealth GLP-1 provider is legitimate. The FDA issued 30 warning letters in a single day in March 2026. Here's how to protect yourself.
Red Flag #1: Guaranteed Prescriptions
Any provider that promises or guarantees a prescription before you complete a medical evaluation is operating improperly. Legitimate providers evaluate your medical history, BMI, contraindications, and current medications before making a prescribing decision. Payment should never guarantee a prescription.
Red Flag #2: No Medical Provider Interaction
A questionnaire alone isn't a medical consultation. You should have the opportunity to communicate with a licensed provider — whether through async messaging, phone, or video. If the entire process is automated with no human clinical oversight, that's a concern.
Red Flag #3: Unclear Pricing
If you can't find a clear, all-in monthly cost on the provider's website — or if the pricing structure is deliberately confusing with multiple separate fees — be cautious. Legitimate providers are transparent about total costs at every dose level.
Red Flag #4: Unverifiable Pharmacy
The provider should be willing to tell you which pharmacy compounds your medication and whether it's a 503A or 503B facility. If they won't disclose this information, that's a significant warning sign.
Red Flag #5: Safety Claims About Compounded Products
Any provider claiming that compounded GLP-1 medications are "equivalent to" or "just as safe as" FDA-approved versions is making a claim the FDA has specifically flagged as misleading. Compounded medications contain the same active ingredient but haven't undergone the same regulatory review as finished drug products.
Embody · $149 first mo
Find a Vetted Provider →Compounded medications are not FDA-approved. Paid link
Trusted Telehealth Providers
$130/mo sema
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
$146/mo sema
Check Eligibility → Paid linkCompounded medications are not FDA-approved.
The Bottom Line
The GLP-1 telehealth boom brought both innovation and opportunism. Spend 5 minutes checking these red flags before signing up with any provider. The right platform will have transparent pricing, real medical oversight, identifiable pharmacy partners, and honest marketing.
Sources
- FDA warning letters to 30 telehealth companies, March 2026
- FDA consumer advisory on compounded GLP-1 medications